fda approvals in myeloma and head and neck cancer, and findings across several tumor types
Published 7 years ago • 197 plays • Length 9:24
Download video MP4
Download video MP3
Similar videos
-
0:31
preview: approvals in myeloma and head and neck cancer, and findings across several tumor types
-
10:23
fda approvals in hematologic malignancies, sbla accepted in multiple myeloma, and more
-
10:08
fda approvals in myeloma and attp, priority review designations in rcc and hnscc, and more
-
10:55
fda approval in myeloma, label update in her2 breast cancer, and more
-
9:57
fda approvals in fl and rcc, breakthrough designation in myeloma, and more
-
10:49
fda approvals in myeloma, nets, and of a biosimilar, priority review in ovarian cancer, and more
-
5:55
fda approval in myeloma, breakthrough designations in rcc and aplastic anemia, and more
-
10:20
fda approvals in myeloma and thyroid cancer, priority review and nda in nsclc, and more
-
10:47
fda approvals in myeloma and itp, applications accepted in myeloma and more
-
6:27
fda approval in myeloma, priority review in all, and 2017 gu cancers symposium highlights
-
8:00
fda approval in rcc, european approvals in myeloma and melanoma, and 2016 aua highlights
-
11:50
fda approval in myeloma, priority review in dlbcl, application accepted of a biosimilar, and more
-
8:29
fda approval in multiple myeloma, priority reviews in dlbcl and myeloma, and more
-
9:17
fda approvals in cscc, nsclc, and myeloma, breakthrough designation in prostate cancer, and more
-
9:02
fda approval in sarcoma, priority reviews in mcrpc and myeloma, and more
-
9:45
fda approval of a biosimilar, promising data in myeloma and gbm, and more
-
0:37
j&j’s carvykti and bms’ abecma win fda approvals for earlier use in multiple myeloma
-
3:26
what does the fda approval of mrd testing for myeloma mean for patients and drug development?
-
10:08
fda approval in waldenstrom macroglobulinemia, priority review and snda in myeloma, and more
Clip.africa.com - Privacy-policy